A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Acid reflux treatment company Torax Medical announced it has raised $30 million in a series D round. The company makes an implant that uses magnetized titanium beads to prevent stomach acid from making its way into the esophagus. MedCity News